Compounds > trimebutine
Page last updated: 2024-11-05

trimebutine and Basal Ganglia Diseases

trimebutine has been researched along with Basal Ganglia Diseases in 1 studies

Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohno, K1
Miyazawa, S1
Hashiguchi, M1
Unemoto, T1
Itoh, A1
Echizen, H1
Rikihisa, T1
Ogata, H1
Murata, M1

Trials

1 trial available for trimebutine and Basal Ganglia Diseases

ArticleYear
Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2003, Volume: 123, Issue:10

    Topics: Aged; Basal Ganglia Diseases; Benzamides; Benzyl Compounds; Cisapride; Domperidone; Dopamine Antagon

2003